Literature DB >> 27006696

Nontraumatic spinal cord injury at the neurological intensive care unit: spectrum, causes of admission and predictors of mortality.

Lukas Grassner1, Julia Marschallinger2, Martin W Dünser3, Helmut F Novak4, Alexander Zerbs4, Ludwig Aigner2, Eugen Trinka4, Johann Sellner5.   

Abstract

OBJECTIVE: Nontraumatic spinal cord injuries (NTSCIs) form a heterogeneous group of diseases, which may evolve into a life-threatening condition. We sought to characterize spectrum, causes of admission and predictors of death in patients with NTSCI treated at the neurological intensive care unit (NICU).
METHODS: We performed a retrospective observational analysis of NTSCI cases treated at a tertiary care center between 2001 and 2013. Among the 3937 NICU admissions were 93 patients with NTSCI (2.4%). Using multivariate logistic regression analysis, we examined predictors of mortality including demographics, etiology, reasons for admission and GCS/SAPS (Glasgow Coma Scale/Simplified Acute Physiology Score) scores.
RESULTS: Infectious and inflammatory/autoimmune causes made up 50% of the NTSCI cases. The most common reasons for NICU admission were rapidly progressing paresis (49.5%) and abundance of respiratory insufficiency (26.9%). The mortality rate was 22.6% and 2.5-fold higher than in the cohort of all other patients treated at the NICU. Respiratory insufficiency as the reason for NICU admission [odds ratio (OR) 4.97, 95% confidence interval (CI) 1.38-17.9; p < 0.01], high initial SAPS scores (OR 1.04; 95% CI 1.003-1.08; p = 0.04), and the development of acute kidney injury throughout the stay (OR 7.25, 1.9-27.5; p = 0.004) were independent risk factors for NICU death.
CONCLUSIONS: Patients with NTSCI account for a subset of patients admitted to the NICU and are at risk for adverse outcome. A better understanding of predisposing conditions and further knowledge of management of critically ill patients with NTSCI is mandatory.

Entities:  

Keywords:  intensive care; mortality; nontraumatic spinal cord injury; treatment

Year:  2015        PMID: 27006696      PMCID: PMC4784250          DOI: 10.1177/1756285615621687

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  34 in total

1.  Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  T F Scott; E M Frohman; J De Seze; G S Gronseth; B G Weinshenker
Journal:  Neurology       Date:  2011-12-07       Impact factor: 9.910

2.  Treatment results of spinal cord injuries in the Swiss Parplegic Centre of Basle.

Authors:  G A Zäch; W Seiler; P Dollfus
Journal:  Paraplegia       Date:  1976-05

3.  Epidemiology of traumatic spinal cord injuries in Austria 2002-2012.

Authors:  Marek Majdan; Alexandra Brazinova; Walter Mauritz
Journal:  Eur Spine J       Date:  2015-05-09       Impact factor: 3.134

4.  EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.

Authors:  Peter M Andersen; Sharon Abrahams; Gian D Borasio; Mamede de Carvalho; Adriano Chio; Philip Van Damme; Orla Hardiman; Katja Kollewe; Karen E Morrison; Susanne Petri; Pierre-Francois Pradat; Vincenzo Silani; Barbara Tomik; Maria Wasner; Markus Weber
Journal:  Eur J Neurol       Date:  2011-09-14       Impact factor: 6.089

5.  Pulmonary complications of acute spinal cord injuries.

Authors:  H D Reines; R C Harris
Journal:  Neurosurgery       Date:  1987-08       Impact factor: 4.654

6.  Management of acute spinal cord injuries.

Authors:  C H Tator; D W Rowed; M L Schwartz; S D Gertzbein; N Bharatwal; M Barkin; V E Edmonds
Journal:  Can J Surg       Date:  1984-05       Impact factor: 2.089

Review 7.  Diagnosis and Treatment of Cervical Radiculopathy and Myelopathy.

Authors:  Jean-Christophe A Leveque; Bintu Marong-Ceesay; Teresa Cooper; Chris R Howe
Journal:  Phys Med Rehabil Clin N Am       Date:  2015-08       Impact factor: 1.784

8.  Critical care capacity in Canada: results of a national cross-sectional study.

Authors:  Robert A Fowler; Philip Abdelmalik; Gordon Wood; Denise Foster; Noel Gibney; Natalie Bandrauk; Alexis F Turgeon; François Lamontagne; Anand Kumar; Ryan Zarychanski; Rob Green; Sean M Bagshaw; Henry T Stelfox; Ryan Foster; Peter Dodek; Susan Shaw; John Granton; Bernard Lawless; Andrea Hill; Louise Rose; Neill K Adhikari; Damon C Scales; Deborah J Cook; John C Marshall; Claudio Martin; Philippe Jouvet
Journal:  Crit Care       Date:  2015-04-01       Impact factor: 9.097

9.  Scoring Systems in Assessing Survival of Critically Ill ICU Patients.

Authors:  Ana D Sekulic; Sladjana V Trpkovic; Aleksandar P Pavlovic; Olivera M Marinkovic; Aleksandra N Ilic
Journal:  Med Sci Monit       Date:  2015-09-04

Review 10.  Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).

Authors:  John A Kellum; Norbert Lameire
Journal:  Crit Care       Date:  2013-02-04       Impact factor: 9.097

View more
  3 in total

1.  Clinical Presentation and Causes of Non-traumatic Spinal Cord Injury: An Observational Study in Emergency Patients.

Authors:  Leonie Müller-Jensen; Christoph Johannes Ploner; Daniel Kroneberg; Wolf Ulrich Schmidt
Journal:  Front Neurol       Date:  2021-08-09       Impact factor: 4.003

2.  Spontaneous spinal cord infarction in Austria: a two-center comparative study.

Authors:  Slaven Pikija; Alexander B Kunz; Raffaele Nardone; Christian Enzinger; Johannes A R Pfaff; Eugen Trinka; Thomas Seifert-Held; Johann Sellner
Journal:  Ther Adv Neurol Disord       Date:  2022-03-11       Impact factor: 6.570

3.  A prospective cohort study investigating contributors to mild cognitive impairment in adults with spinal cord injury: study protocol.

Authors:  Danielle Sandalic; Ashley Craig; Mohit Arora; Ilaria Pozzato; Grahame Simpson; Bamini Gopinath; Jasbeer Kaur; Sachin Shetty; Gerard Weber; Ian Cameron; Yvonne Tran; James Middleton
Journal:  BMC Neurol       Date:  2020-09-11       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.